← Today’s ReceiptsOfficial public filing linked
Public-record receiptR-PAOfficial filing linked
Daniel Meuser disclosed SELL $V
Here’s the public record: who traded, what they disclosed, when it happened, how late it appeared, and what context is attached.
Trade range
$15K – $50K
Filed
2025-08-20
Trade date
2025-02-11
Disclosure lag
190 days after trade
Why this receipt matters
A quick read before you share it.
These are factual context points from the receipt and linked public-record data. They explain why the disclosure may be worth opening, not whether anyone acted improperly.
1The receipt links to an official public filing, so readers can verify the underlying disclosure before sharing.
2The filing appeared 190 days after the trade date, beyond the standard 45-day STOCK Act window.
3The disclosed range is $15K – $50K, which is the public reporting band rather than an exact profit or loss figure.
416 nearby same-ticker disclosures appeared in the surrounding 30-day window.
5Committee context is available for Daniel Meuser, but PoliWealth treats it as context - not proof of intent or wrongdoing.
6Related public-record context includes 13 lobbying filings.
Source
Official filing ↗
Source: official House/Senate financial disclosure record · filing ID 20030922 · filed 2025-08-20 · disclosed 190d after transaction
Market context
Visa Inc.
Sector: Financials
Vs SPY: -28.7%
Factual flags
- Filed after the standard 45-day STOCK Act window.
- 13 lobbying filings linked to this ticker.
- 16 nearby same-ticker disclosures in the surrounding 30-day window.
- Filed 190 days after transaction (STOCK Act limit: 45)
- Traded V 21d after lobbying filing by VISA INC. ($2,060,000) (committee overlap: Financials)
- Sits on committee with jurisdiction over finance/banking sector — traded V on 2025-02-11
- 9 trades filed on 2025-08-20 (batch dump)
Member trail
Daniel Meuser
U.S. House · PA-9
House Committee on Financial ServicesHouse Committee on Small Business
Ticker trail
$V
Visa Inc.
Follow this tickerAlert me when this ticker gets a new congressional receipt. This page reports public disclosures and factual context only. It does not determine intent, is not an accusation, and is not investment advice.